Literature DB >> 18329955

Electrical stimulation of primary motor cortex within the central sulcus for intractable neuropathic pain.

Koichi Hosomi1, Youichi Saitoh, Haruhiko Kishima, Satoru Oshino, Masayuki Hirata, Naoki Tani, Toshio Shimokawa, Toshiki Yoshimine.   

Abstract

OBJECTIVE: To assess the pain-relieving effects of motor cortex electrical stimulation (MCS) within the central sulcus and the predictive factors retrospectively.
METHODS: Thirty-four patients with intractable neuropathic pain underwent MCS; 19 patients had cerebral lesions, and 15 had non-cerebral lesions. In selected 12 patients, test electrodes were implanted within the central sulcus and on the precentral gyrus. Twelve patients received both MCS and repetitive transcranial magnetic stimulation (rTMS) of the primary motor cortex.
RESULTS: Pain reduction of > or =50% was observed in 12 of 32 (36%) patients with > or =12 months follow-ups (2 patients were excluded because of short follow-up). In 10 of the 12 patients who received test electrodes within the central sulcus and on the precentral gyrus, the optimal stimulation was MCS within the central sulcus. In 4 of these (40%) patients, positive effects were maintained at follow-ups. The pain reduction of rTMS significantly correlated with that of MCS during test stimulation.
CONCLUSIONS: The test stimulation within the central sulcus was more effective than that of the precentral gyrus. In the selected patients, chronic stimulation within the central sulcus did not significantly improve long-term results. SIGNIFICANCE: The present findings suggest that an intra-central sulcus is one of the favorable targets for MCS.

Entities:  

Mesh:

Year:  2008        PMID: 18329955     DOI: 10.1016/j.clinph.2007.12.022

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  17 in total

Review 1.  Invasive brain stimulation for the treatment of neuropathic pain.

Authors:  Jean-Paul Nguyen; Julien Nizard; Yves Keravel; Jean-Pascal Lefaucheur
Journal:  Nat Rev Neurol       Date:  2011-09-20       Impact factor: 42.937

Review 2.  Motor Cortex Stimulation for Deafferentation Pain.

Authors:  Ahmed E Hussein; Darian R Esfahani; Galina I Moisak; Jamil A Rzaev; Konstantin V Slavin
Journal:  Curr Pain Headache Rep       Date:  2018-05-23

3.  Application of optogenetics-mediated motor cortex stimulation in the treatment of chronic neuropathic pain.

Authors:  Sufang Liu; Feng Tao
Journal:  J Transl Sci       Date:  2016-07-11

Review 4.  Modulating the pain network--neurostimulation for central poststroke pain.

Authors:  Koichi Hosomi; Ben Seymour; Youichi Saitoh
Journal:  Nat Rev Neurol       Date:  2015-04-21       Impact factor: 42.937

5.  Antinociception by motor cortex stimulation in the neuropathic rat: does the locus coeruleus play a role?

Authors:  Hanna Viisanen; Antti Pertovaara
Journal:  Exp Brain Res       Date:  2009-10-14       Impact factor: 1.972

6.  New Developments in Non-invasive Brain Stimulation in Chronic Pain.

Authors:  Timothy J Meeker; Rithvic Jupudi; Frederik A Lenz; Joel D Greenspan
Journal:  Curr Phys Med Rehabil Rep       Date:  2020-05-11

7.  Motor cortex stimulation for facial chronic neuropathic pain: A review of the literature.

Authors:  Guillermo A Monsalve
Journal:  Surg Neurol Int       Date:  2012-10-31

8.  Computational Modeling of Subdural Cortical Stimulation: A Quantitative Spatiotemporal Analysis of Action Potential Initiation in a High-Density Multicompartment Model.

Authors:  Pawel Kudela; William S Anderson
Journal:  Neuromodulation       Date:  2015-08-05

9.  Computational study on subdural cortical stimulation - the influence of the head geometry, anisotropic conductivity, and electrode configuration.

Authors:  Donghyeon Kim; Hyeon Seo; Hyoung-Ihl Kim; Sung Chan Jun
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

Review 10.  Role of Neuromodulation and Optogenetic Manipulation in Pain Treatment.

Authors:  Sufang Liu; Changsheng Li; Ying Xing; Yanqing Wang; Feng Tao
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.